Search
Antitrust significantly impacts commercial business throughout the United States – from monopoly lawsuits against Big Tech to horizontal price-fixing cases to the development of antitrust compliance programs for start-ups. Irrespective of size, businesses must comply with antitrust laws, trade...
The Inflation Reduction Act is driving unprecedented investment in renewable energy development in the United States, while the Energy Information Administration forecasts that natural gas development in the United States will continue to grow through 2050. Concerns about climate change are driving...
As the U.S. seeks to jumpstart a hydrogen economy with the creation of Regional Clean Hydrogen Hubs (H2Hubs), Saul Ewing stands ready to advise clients in the energy, transportation, industrial, manufacturing and agribusiness industries on next steps. The H2Hubs will accelerate the commercial-scale...
David Shapiro advises clients on international and domestic business tax planning, including domestic and cross border expansion, joint ventures, mergers, acquisitions, and financing transactions. David's practice includes entity formation and structure planning, securities offerings and hybrid...
Domingos Silva is co-chair of the firm's Intellectual Property Practice with extensive experience in the pharmaceutical, chemical, biotechnology, diagnostics, biochemistry, and materials science areas. Domingos has a Ph.D. in Organic Chemistry from Princeton University and conducted his post...
Dan Skowronski joined Saul Ewing in 2008 after having provided legal services to a national energy company and its affiliates in various in-house capacities between 1986 and 2008, as well as holding various executive leadership positions with that family of companies. Dan has broad experience in...
Evan Foster advises clients on legal issues involving technology, data privacy and cybersecurity. Customers and vendors in the health care, life sciences, financial and manufacturing industries, among others, seek his advice on technology transactions and systems acquisition including matters...
Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...
In response to the ongoing challenges to their profits, pharmaceutical and other life sciences companies continue to outsource many specialized services. From R&D to manufacturing – and everything in between – opportunities abound for companies that have the knowledge and expertise to effectively...